2024 annual financial data
MIRA Pharmaceuticals 2024 Net income growth
Direct answer
Net income growth was 34.46%.
Operating income was -8,018,328 USD and net income was -7,852,659 USD.
Operating cash flow was -5,560,606 USD.
Get free MIRA Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -8,018,328 USD
- Net income
- -7,852,659 USD
- Operating cash flow
- -5,560,606 USD